JUNCTIONAL EPIDERMOLYSIS BULLOSA
Clinical trials for JUNCTIONAL EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new JUNCTIONAL EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for JUNCTIONAL EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cell therapy offers hope for children with butterfly skin
Disease control OngoingThis study tests a stem cell treatment for epidermolysis bullosa, a rare disease causing fragile skin that blisters easily. About 91 people with two types of EB will receive the cells or a placebo through an IV. The main goal is to see if the treatment can safely close stubborn w…
Matched conditions: JUNCTIONAL EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Stem cell trial aims to heal wounds in 'Butterfly Skin' disease
Disease control OngoingThis phase 3 trial tests whether ABCB5-positive stem cells given through an IV can safely and effectively heal wounds in people with epidermolysis bullosa, a rare genetic condition that causes fragile, blistering skin. The study includes 9 participants with a specific type of the…
Matched conditions: JUNCTIONAL EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New eye drops aim to soothe blistering eye pain in rare skin disease
Symptom relief OngoingThis early-stage study tests whether ELK-003 eye drops can safely reduce eye symptoms in people with two types of epidermolysis bullosa (EB), a rare condition causing fragile skin and blisters. About 20 participants will first be observed without treatment, then receive the eye d…
Matched conditions: JUNCTIONAL EPIDERMOLYSIS BULLOSA
Phase: PHASE1 • Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC